Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.25
+0.18 (0.66%)
At close: Aug 6, 2026, 4:00 PM EDT
27.36
+0.11 (0.40%)
Pre-market: Aug 7, 2026, 4:18 AM EDT

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $490.00K in the quarter ending June 30, 2026, a decrease of -94.21%. This brings the company's revenue in the last twelve months to $156.04M, up 158.88% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth.

Revenue (ttm)
$156.04M
Revenue Growth
+158.88%
P/S Ratio
17.45
Revenue / Employee
$298,918
Employees
522
Market Cap
2.72B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ultragenyx Pharmaceutical670.00M
Tarsus Pharmaceuticals535.08M
Vericel306.30M
Nektar Therapeutics55.63M
Nurix Therapeutics36.77M
Precigen31.60M
Immunome4.02M
AtaiBeckley3.49M
Revenue Rankings

BEAM News

More News